Search results for BRG1 antibody

BRG1 antibody [GT2712], Genetex, GTX633391

Anti-BRG1 antibody, Abcam, AB4081

BRG1 antibody [6D7], Genetex, GTX66842

Brg1 antibody (BRG-01), Covalab, Ref 00113499

BRG1 antibody [BRG-01], Genetex, GTX80217

Anti-BRG1 antibody [EPNCIR111A], Abcam, AB110641

Anti-BRG1 antibody [EPNCIR111A] (ab110641) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ChIC/CUT&RUN-seq, Flow Cyt (Intra), ICC/IF, IHC-P, IP and WB. Anti-BRG1 antibody [EPNCIR111A] (ab110641) was first used in a scientific publication in 2014 and has been cited over 191 times in peer reviewed journals. It's performance in Western Blot, ChIP and IHC in human samples is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-BRG1 antibody [EPNCIR111A] (ab110641) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-BRG1 antibody [EPNCIR111A] (ab110641) has been confirmed by Western Blot testing in BRG1 knockout HEK-293T cells ( ab263853 ). Anti-BRG1 antibody [EPNCIR111A] (ab110641) has 9 independent reviews from customers. Anti-BRG1 antibody [EPNCIR111A] (ab110641) specifically detects BRG1 (UniProt ID: Q3TKT4; Molecular weight: 182kDa) and is sold in a convenient trial size to enable initial testing (10 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL). Conjugation-ready, carrier free format available for antibody clone EPNCIR111A - ab215998 . Antibody clone EPNCIR111A is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 488, HRP, Alexa Fluor ® 647, Alexa Fluor ® 594, PE, APC ( ab196314 , ab196315 , ab196535 , ab207052 , ab225124 , ab314953 ). Top cited antibody for this target with >200 citations. Validated for CUT&RUN-seq, a key application to map protein-DNA interactions on a genome-wide scale using NGS. Key target in SWI/SNF chromatin remodeling and epigenetic regulation. This antibody is crucial in cancer research, particularly in understanding BRG1's role as a tumor suppressor and its involvement in cell proliferation and gene expression. It is widely used in studies of BRG1's impact on leukaemia, breast cancer and other malignancies. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . Collaborations This antibody was developed as part of a collaboration between Epitomics, the National Cancer Institute's Center for Cancer Research and the lab of Gordon Hager. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-BRG1 antibody [EPNCIR111B], Abcam, AB133257

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . Collaborations This antibody was developed as part of a collaboration between Epitomics, the National Cancer Institute's Center for Cancer Research and the lab of Gordon Hager. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-BRG1 antibody [EPR3912], Abcam, AB108318

Anti-BRG1 antibody [EPR3912] (ab108318) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ChIC/CUT&RUN-seq, Flow Cyt (Intra), ICC/IF, IHC-P, IP, and WB. Abcam's high quality manufacturing and validation processes ensure Anti-BRG1 antibody [EPR3912] (ab108318) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-BRG1 antibody [EPR3912] (ab108318) has been confirmed by Western Blot testing in BRG1 knockout HEK-293T cells ( ab263853 ). Anti-BRG1 antibody [EPR3912] (ab108318) specifically detects BRG1 (UniProt ID: P51532; Molecular weight: 185kDa) and is sold in 100 µL and 1 mL selling sizes. Conjugation-ready, carrier free format available for antibody clone EPR3912 - ab222230 . Antibody clone EPR3912 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 647, Alexa Fluor ® 488, PE, APC, HRP, Alkaline Phosphatase, Alexa Fluor ® 594, Alexa Fluor ® 555, Alexa Fluor ® 568, Alexa Fluor ® 750 ( ab206598 , ab206712 , ab305626 , ab305627 , ab305628 , ab308772 , ab310487 , ab312016 , ab312493 , ab320893 ). Validated for CUT&RUN-seq, a key application to map protein-DNA interactions on a genome-wide scale using NGS. Highly specific BRG1 antibody, essential for researchers studying the SWI/SNF complex and chromatin remodeling. BRG1 is widely studied in the context of epigenetic regulation, BRG1 mutations, and cancer research. The BRM/BRG1-containing SWI/SNF complexes are recruited by transcription factors like p53 and BRCA1 to regulate gene activation, cell growth, and differentiation. BRM and BRG1 act as tumor suppressors, with their expression significantly reduced in various cancer cell lines. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-BRG1 antibody [EPR3913], Abcam, AB92496

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Species reactivity Rat: We have preliminary internal testing data to indicate this antibody may not react with this species. Please contact us for more information.

HRP Anti-BRG1 antibody [EPNCIR111A], Abcam, AB196315

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .